Outsourcing predictive biomarker testing in non-small cell carcinoma: a personal view of pathologists.
作者信息
Brcic Luka, Kern Izidor
机构信息
Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Cytology and Pathology Laboratory, University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.
出版信息
Transl Lung Cancer Res. 2020 Oct;9(5):2194-2198. doi: 10.21037/tlcr-20-297.
Abstract
摘要
相似文献
1
Outsourcing predictive biomarker testing in non-small cell carcinoma: a personal view of pathologists.非小细胞肺癌中预测性生物标志物检测的外包：病理学家的个人观点
Transl Lung Cancer Res. 2020 Oct;9(5):2194-2198. doi: 10.21037/tlcr-20-297.
2
Outsourcing cytological samples to a referral laboratory for EGFR testing in non-small cell lung cancer: does theory meet practice?将非小细胞肺癌的细胞学样本外包给转诊实验室进行表皮生长因子受体（EGFR）检测：理论与实践相符吗？
Cytopathology. 2015 Oct;26(5):312-7. doi: 10.1111/cyt.12221. Epub 2014 Nov 7.
3
Non-Small Cell Lung Carcinoma Biomarker Testing: The Pathologist's Perspective.非小细胞肺癌生物标志物检测：病理学家的视角。
Front Oncol. 2014 Jul 16;4:182. doi: 10.3389/fonc.2014.00182. eCollection 2014.
4
[IT Outsourcing and Medical Secrecy].
Praxis (Bern 1994). 2019;108(3):175-178. doi: 10.1024/1661-8157/a003165.
5
Small but powerful: the promising role of small specimens for biomarker testing.体积虽小，作用巨大：小标本在生物标志物检测中的应用前景广阔。
J Am Soc Cytopathol. 2020 Sep-Oct;9(5):450-460. doi: 10.1016/j.jasc.2020.05.001. Epub 2020 May 12.
6
Home care outsourcing strategy.居家护理外包策略。
J Health Organ Manag. 2006;20(2-3):175-93. doi: 10.1108/14777260610662726.
7
The impact of a pathologist's personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer.病理学家的个性对肺癌中预测性PD-L1免疫组化的观察者间变异性和诊断准确性的影响。
Lung Cancer. 2022 Apr;166:143-149. doi: 10.1016/j.lungcan.2022.03.002. Epub 2022 Mar 5.
8
[Outsourcing. Advantages and disadvantages of these processes with regard to the management from the view of the technical services in a hospital].[外包。从医院技术服务管理的角度看这些流程的优缺点]
Bull Soc Sci Med Grand Duche Luxemb. 1999(4):57-63.
9
Impacts of outsourcing in educational hospitals in Iran: A study on Isfahan University of Medical Sciences-2010.外包对伊朗教学医院的影响：针对伊斯法罕医科大学的一项研究 - 2010年
J Educ Health Promot. 2012;1:25. doi: 10.4103/2277-9531.99959. Epub 2012 Aug 22.
10
Concerns and hopes about outsourcing decisions regarding health information management services at two teaching hospitals in Semnan, Iran.关于伊朗塞姆南两所教学医院的卫生信息管理服务外包决策的关注和希望。
Health Inf Manag. 2016 Apr;45(1):36-44. doi: 10.1177/1833358316639455.
引用本文的文献
1
Seize the Opportunity With Small Tissue Samples: The Tailor Teaches!抓住小组织样本带来的机遇：裁缝的启示！
JTO Clin Res Rep. 2023 Mar 24;4(4):100507. doi: 10.1016/j.jtocrr.2023.100507. eCollection 2023 Apr.
2
BRAF Testing in Melanoma and Colorectal Cancer in Latin America: Challenges and Opportunities.拉丁美洲黑色素瘤和结直肠癌中的BRAF检测：挑战与机遇
Cureus. 2022 Nov 28;14(11):e31972. doi: 10.7759/cureus.31972. eCollection 2022 Nov.
3
Combination of albumin concentration and neutrophil-to-lymphocyte ratio for predicting overall survival of patients with non-small cell lung cancer.白蛋白浓度与中性粒细胞与淋巴细胞比值联合用于预测非小细胞肺癌患者的总生存期
J Thorac Dis. 2021 Sep;13(9):5508-5516. doi: 10.21037/jtd-21-1320.
本文引用的文献
1
KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne?KRAS G12C 权游，谁是 KRAS 抑制剂的铁王座之王？
Cancer Treat Rev. 2020 Mar;84:101974. doi: 10.1016/j.ctrv.2020.101974. Epub 2020 Jan 23.
2
Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.全自动基于 PCR 的 Idylla EGFR 突变检测在福尔马林固定石蜡包埋人类肺癌组织中的多中心评估。
J Mol Diagn. 2019 Nov;21(6):1010-1024. doi: 10.1016/j.jmoldx.2019.06.010. Epub 2019 Aug 22.
3
Rapid clinical mutational testing of , and : a prospective comparative analysis of the Idylla technique with high-throughput next-generation sequencing.快速临床基因突变检测、和：Idylla 技术与高通量下一代测序的前瞻性对比分析。
J Clin Pathol. 2020 Jan;73(1):35-41. doi: 10.1136/jclinpath-2019-205970. Epub 2019 Jul 11.
4
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.转移性非小细胞肺癌：欧洲肿瘤内科学会临床实践诊断、治疗及随访指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237. doi: 10.1093/annonc/mdy275.
5
Accreditation, setting and experience as indicators to assure quality in oncology biomarker testing laboratories.认证、设置和经验作为保证肿瘤标志物检测实验室质量的指标。
Br J Cancer. 2018 Aug;119(5):605-614. doi: 10.1038/s41416-018-0204-9. Epub 2018 Aug 24.
6
Toward a Molecular Diagnosis in a Single Day for Patients With Advanced Non-small-cell Lung Cancer.迈向晚期非小细胞肺癌患者的单日分子诊断
Clin Lung Cancer. 2018 Sep;19(5):e537-e538. doi: 10.1016/j.cllc.2018.03.002. Epub 2018 May 5.
7
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.美国病理学家学会、国际肺癌研究协会和分子病理学会更新的肺癌患者靶向酪氨酸激酶抑制剂治疗选择的分子检测指南。
Arch Pathol Lab Med. 2018 Mar;142(3):321-346. doi: 10.5858/arpa.2017-0388-CP. Epub 2018 Jan 22.
8
Molecular Testing Turnaround Time for Non-Small Cell Lung Cancer in Routine Clinical Practice Confirms Feasibility of CAP/IASLC/AMP Guideline Recommendations: A Single-center Analysis.常规临床实践中非小细胞肺癌分子检测周转时间证实了CAP/IASLC/AMP指南建议的可行性：一项单中心分析
Clin Lung Cancer. 2017 Sep;18(5):e349-e356. doi: 10.1016/j.cllc.2017.03.001. Epub 2017 Mar 14.
9
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.《2015年世界卫生组织肺、胸膜、胸腺和心脏肿瘤分类》简介
J Thorac Oncol. 2015 Sep;10(9):1240-1242. doi: 10.1097/JTO.0000000000000663.
10
Outsourcing cytological samples to a referral laboratory for EGFR testing in non-small cell lung cancer: does theory meet practice?将非小细胞肺癌的细胞学样本外包给转诊实验室进行表皮生长因子受体（EGFR）检测：理论与实践相符吗？
Cytopathology. 2015 Oct;26(5):312-7. doi: 10.1111/cyt.12221. Epub 2014 Nov 7.
Zotero 插件